Fidelity Investments’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-386
Closed -$5.97K 5585
2023
Q3
$5.97K Sell
386
-488
-56% -$9.31K ﹤0.01% 4291
2023
Q2
$18.9K Sell
874
-801
-48% -$15.8K ﹤0.01% 3889
2023
Q1
$29.7K Buy
1,675
+419
+33% +$8.07K ﹤0.01% 3665
2022
Q4
$21.3K Sell
1,256
-26,819
-96% -$617K ﹤0.01% 3759
2022
Q3
$926K Hold
28,075
﹤0.01% 2627
2022
Q2
$1.58M Buy
+28,075
New +$1.47M ﹤0.01% 2564
2022
Q1
Sell
-21
Closed -$2K 5329
2021
Q4
$2K Sell
21
-15
-42% -$1.25K ﹤0.01% 4031
2021
Q3
$3K Buy
36
+8
+29% +$701 ﹤0.01% 3915
2021
Q2
$3K Sell
28
-1,263
-98% -$129K ﹤0.01% 3850
2021
Q1
$155K Sell
1,291
-17
-1% -$2.46K ﹤0.01% 2860
2020
Q4
$171K Sell
1,308
-11,066
-89% -$1.43M ﹤0.01% 2805
2020
Q3
$1.31M Hold
12,374
﹤0.01% 2381
2020
Q2
$3.18M Hold
12,374
﹤0.01% 2174
2020
Q1
$5.5M Hold
12,374
﹤0.01% 1902
2019
Q4
$8.36M Buy
+12,374
New +$6.21M ﹤0.01% 1908

Other funds holding NXTC

Fidelity Investments's NXTC Position: Q4 2023 in Review

Fidelity Investments sold out of NextCure (NXTC) in Q4 2023, closing a stake of 386 shares — an estimated $5.97K sold.

Fidelity Investments first reported a position in NXTC in Q4 2019 and held it in 15 quarters. The position peaked at $8.36M in Q4 2019. 43 funds tracked by Wall St. Rank hold NXTC as of Q4 2023.

  • Fidelity Investments reported no remaining NextCure position as of Q4 2023 after selling out during the quarter.
  • Fidelity Investments sold 386 NextCure shares in Q4 2023, an estimated $5.97K.
  • Fidelity Investments first reported a position in NextCure in Q4 2019 and held it in 15 quarters.
  • Fidelity Investments's NextCure position peaked at $8.36M in Q4 2019.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.